• Je něco špatně v tomto záznamu ?

Long-term visual damage after acute methanol poisonings: Longitudinal cross-sectional study in 50 patients

S. Zakharov, D. Pelclova, P. Diblik, P. Urban, P. Kuthan, O. Nurieva, K. Kotikova, T. Navratil, M. Komarc, J. Belacek, Z. Seidl, M. Vaneckova, JA. Hubacek, O. Bezdicek, J. Klempir, M. Yurchenko, E. Ruzicka, M. Miovsky, B. Janikova, KE. Hovda,

. 2015 ; 53 (9) : 884-92. [pub] 20150912

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc16009964

CONTEXT: Visual disturbances due to the toxic effect of formic acid in acute methanol poisonings are generally transient. The subjective symptoms of visual toxicity may resolve within few weeks and fundoscopic signs of acute optic neuropathy subside within 1-2 months; therefore, the prevalence of long-term visual sequelae in the population of survivors of poisonings may be underestimated. OBJECTIVE: To study the prevalence and character of long-term visual sequelae of acute methanol poisonings based on the data from the Czech mass methanol outbreak in 2012. PATIENTS AND METHODS: A total of 50 patients with confirmed methanol poisoning were included in this longitudinal cross-sectional study, median age: 48 (range, 23-73) years. The following tests were performed: optical coherence tomography or OCT with evaluation of the retinal nerve fibers layer (RNFL), visual evoked potentials (VEP), magnetic resonance imaging (MRI) of brain, complete ocular examination (visual acuity/field, color vision, contrast sensitivity, and fundus), neurological examinations, and biochemical tests. RESULTS: Of 50 patients, 7/50 (14%) were discharged with diagnosed visual sequelae and 6/50 (12%) were discharged with both visual and central nervous system sequelae of poisoning. On the follow-up examination, 20/50 (40%) of the patients had long-term visual sequelae, with 8% of blindness. A total of 38% of the patients had abnormal (28% borderline) findings on RNFL, and 40% had abnormal (18% borderline) VEP. Among the patients discharged without detected visual sequelae, 8/37 (22%) had abnormal RNFL and VEP. Patients with visual sequelae had brain lesions more often (70% vs. 27%, p < 0.01). MRI identified optic nerve lesions in 2/20 cases with abnormal VEP only. The groups with and without visual sequelae differed in serum methanol, ethanol, HCO3-, formate, pH, anion gap, and base deficit (all p < 0.01). Visual disturbances on admission and coma were more prevalent in the patients with visual sequelae (p < 0.05). Patients with positive serum ethanol on admission were 93% less likely to have optical axonal damage (OR: 0.07 (95% CI: 0.01-0.8); p < 0.05). No association was found between visual sequelae and type of antidote administered, mode of hemodialysis, or folate substitution. Pre-hospital administration of ethanol seemed beneficial: these patients were 90% less likely to have abnormal RNFL findings (OR: 0.10 (95% CI: 0.02-0.52); p < 0.01). CONCLUSIONS: The long-term visual sequelae were clearly underestimated on discharge, suggesting a significantly higher amount of patients with long-term sequelae than earlier reported. Thorough examinations before discharge and during follow-up will likely uncover a higher morbidity also after methanol poisonings in general.

b Department of Ophthalmology 1st Faculty of Medicine Charles University Prague and General University Hospital Prague 2 Czech Republic

c Department of Biomimetic Electrochemistry J Heyrovský Institute of Physical Chemistry of the AS CR v v i Prague 8 Czech Republic d Institute of Medical Biochemistry and Laboratory Medicine 1st Faculty of Medicine Charles University Prague and General University Hospital Prague Prague 2 Czech Republic

e Institute of Biophysics and Informatics 1st Faculty of Medicine of Charles University Prague General University Hospital Prague 2 Czech Republic

f Department of Radiology 1st Faculty of Medicine Charles University Prague and General University Hospital Prague 2 Czech Republic

g Centre for Experimental Medicine Institute for Clinical and Experimental medicine Prague 4 Czech Republic

h Department of Neurology and Center of Clinical Neuroscience 1st Faculty of Medicine Charles University Prague and General University Hospital Prague 2 Czech Republic

i Institute of Clinical and Experimental Dental Medicine 1st Faculty of Medicine Charles University Prague and General University Hospital Prague 2 Czech Republic

j Department of Addictology 1st Faculty of Medicine Charles University Prague and General University Hospital Prague 2 Czech Republic

k The Norwegian CBRNe Centre of Medicine Department of Acute Medicine Oslo University Hospital Oslo Norway

Toxicological Information Center Department of Occupational Medicine 1st Faculty of Medicine Charles University Prague and General University Hospital Prague 2 Czech Republic

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc16009964
003      
CZ-PrNML
005      
20160413094945.0
007      
ta
008      
160408s2015 enk f 000 0|eng||
009      
AR
024    7_
$a 10.3109/15563650.2015.1086488 $2 doi
024    7_
$a 10.3109/15563650.2015.1086488 $2 doi
035    __
$a (PubMed)26364866
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Zakharov, Sergey $u a Toxicological Information Center, Department of Occupational Medicine , First Faculty of Medicine, Charles University in Prague and General University Hospital , Prague 2, Czech Republic.
245    10
$a Long-term visual damage after acute methanol poisonings: Longitudinal cross-sectional study in 50 patients / $c S. Zakharov, D. Pelclova, P. Diblik, P. Urban, P. Kuthan, O. Nurieva, K. Kotikova, T. Navratil, M. Komarc, J. Belacek, Z. Seidl, M. Vaneckova, JA. Hubacek, O. Bezdicek, J. Klempir, M. Yurchenko, E. Ruzicka, M. Miovsky, B. Janikova, KE. Hovda,
520    9_
$a CONTEXT: Visual disturbances due to the toxic effect of formic acid in acute methanol poisonings are generally transient. The subjective symptoms of visual toxicity may resolve within few weeks and fundoscopic signs of acute optic neuropathy subside within 1-2 months; therefore, the prevalence of long-term visual sequelae in the population of survivors of poisonings may be underestimated. OBJECTIVE: To study the prevalence and character of long-term visual sequelae of acute methanol poisonings based on the data from the Czech mass methanol outbreak in 2012. PATIENTS AND METHODS: A total of 50 patients with confirmed methanol poisoning were included in this longitudinal cross-sectional study, median age: 48 (range, 23-73) years. The following tests were performed: optical coherence tomography or OCT with evaluation of the retinal nerve fibers layer (RNFL), visual evoked potentials (VEP), magnetic resonance imaging (MRI) of brain, complete ocular examination (visual acuity/field, color vision, contrast sensitivity, and fundus), neurological examinations, and biochemical tests. RESULTS: Of 50 patients, 7/50 (14%) were discharged with diagnosed visual sequelae and 6/50 (12%) were discharged with both visual and central nervous system sequelae of poisoning. On the follow-up examination, 20/50 (40%) of the patients had long-term visual sequelae, with 8% of blindness. A total of 38% of the patients had abnormal (28% borderline) findings on RNFL, and 40% had abnormal (18% borderline) VEP. Among the patients discharged without detected visual sequelae, 8/37 (22%) had abnormal RNFL and VEP. Patients with visual sequelae had brain lesions more often (70% vs. 27%, p < 0.01). MRI identified optic nerve lesions in 2/20 cases with abnormal VEP only. The groups with and without visual sequelae differed in serum methanol, ethanol, HCO3-, formate, pH, anion gap, and base deficit (all p < 0.01). Visual disturbances on admission and coma were more prevalent in the patients with visual sequelae (p < 0.05). Patients with positive serum ethanol on admission were 93% less likely to have optical axonal damage (OR: 0.07 (95% CI: 0.01-0.8); p < 0.05). No association was found between visual sequelae and type of antidote administered, mode of hemodialysis, or folate substitution. Pre-hospital administration of ethanol seemed beneficial: these patients were 90% less likely to have abnormal RNFL findings (OR: 0.10 (95% CI: 0.02-0.52); p < 0.01). CONCLUSIONS: The long-term visual sequelae were clearly underestimated on discharge, suggesting a significantly higher amount of patients with long-term sequelae than earlier reported. Thorough examinations before discharge and during follow-up will likely uncover a higher morbidity also after methanol poisonings in general.
650    _2
$a akutní nemoc $7 D000208
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a bazální ganglia $x účinky léků $x patofyziologie $7 D001479
650    _2
$a rozdělení chí kvadrát $7 D016009
650    _2
$a průřezové studie $7 D003430
650    _2
$a diagnostické techniky oftalmologické $7 D003941
650    12
$a epidemický výskyt choroby $7 D004196
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a lineární modely $7 D016014
650    _2
$a logistické modely $7 D016015
650    _2
$a longitudinální studie $7 D008137
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a methanol $x otrava $7 D000432
650    _2
$a lidé středního věku $7 D008875
650    _2
$a multivariační analýza $7 D015999
650    _2
$a odds ratio $7 D016017
650    _2
$a nervus opticus $x účinky léků $x patofyziologie $7 D009900
650    _2
$a otrava $x diagnóza $x epidemiologie $x patofyziologie $x terapie $7 D011041
650    _2
$a prediktivní hodnota testů $7 D011237
650    _2
$a prevalence $7 D015995
650    _2
$a ochranné faktory $7 D065840
650    _2
$a obnova funkce $7 D020127
650    _2
$a retina $x účinky léků $x patofyziologie $7 D012160
650    _2
$a hodnocení rizik $7 D018570
650    _2
$a rizikové faktory $7 D012307
650    _2
$a časové faktory $7 D013997
650    _2
$a výsledek terapie $7 D016896
650    _2
$a poruchy zraku $x chemicky indukované $x diagnóza $x epidemiologie $x patofyziologie $x terapie $7 D014786
650    _2
$a zrak $x účinky léků $7 D014785
650    _2
$a mladý dospělý $7 D055815
651    _2
$a Česká republika $x epidemiologie $7 D018153
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Pelclova, Daniela $u a Toxicological Information Center, Department of Occupational Medicine , First Faculty of Medicine, Charles University in Prague and General University Hospital , Prague 2, Czech Republic.
700    1_
$a Diblik, Pavel $u b Department of Ophthalmology , First Faculty of Medicine, Charles University in Prague and General University Hospital , Prague 2, Czech Republic.
700    1_
$a Urban, Pavel $u a Toxicological Information Center, Department of Occupational Medicine , First Faculty of Medicine, Charles University in Prague and General University Hospital , Prague 2, Czech Republic.
700    1_
$a Kuthan, Pavel $u b Department of Ophthalmology , First Faculty of Medicine, Charles University in Prague and General University Hospital , Prague 2, Czech Republic.
700    1_
$a Nurieva, Olga $u a Toxicological Information Center, Department of Occupational Medicine , First Faculty of Medicine, Charles University in Prague and General University Hospital , Prague 2, Czech Republic.
700    1_
$a Kotikova, Katerina $u a Toxicological Information Center, Department of Occupational Medicine , First Faculty of Medicine, Charles University in Prague and General University Hospital , Prague 2, Czech Republic.
700    1_
$a Navratil, Tomas $u c Department of Biomimetic Electrochemistry , J. Heyrovský Institute of Physical Chemistry of the AS CR , v.v.i, Prague 8 , Czech Republic. d Institute of Medical Biochemistry and Laboratory Medicine, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague , Prague 2, Czech Republic.
700    1_
$a Komarc, Martin $u e Institute of Biophysics and Informatics, First Faculty of Medicine of Charles University in Prague, General University Hospital , Prague 2, Czech Republic.
700    1_
$a Belacek, Jaromir $u e Institute of Biophysics and Informatics, First Faculty of Medicine of Charles University in Prague, General University Hospital , Prague 2, Czech Republic.
700    1_
$a Seidl, Zdenek $u f Department of Radiology , First Faculty of Medicine, Charles University in Prague and General University Hospital , Prague 2, Czech Republic.
700    1_
$a Vaneckova, Manuela $u f Department of Radiology , First Faculty of Medicine, Charles University in Prague and General University Hospital , Prague 2, Czech Republic.
700    1_
$a Hubacek, Jaroslav A $u g Centre for Experimental Medicine, Institute for Clinical and Experimental medicine , Prague 4 , Czech Republic.
700    1_
$a Bezdicek, Ondrej $u h Department of Neurology and Center of Clinical Neuroscience , First Faculty of Medicine, Charles University in Prague and General University Hospital , Prague 2, Czech Republic.
700    1_
$a Klempir, Jiri $u h Department of Neurology and Center of Clinical Neuroscience , First Faculty of Medicine, Charles University in Prague and General University Hospital , Prague 2, Czech Republic.
700    1_
$a Yurchenko, Maksim $u i Institute of Clinical and Experimental Dental Medicine, First Faculty of Medicine, Charles University in Prague and General University Hospital , Prague 2, Czech Republic.
700    1_
$a Ruzicka, Evzen $u h Department of Neurology and Center of Clinical Neuroscience , First Faculty of Medicine, Charles University in Prague and General University Hospital , Prague 2, Czech Republic.
700    1_
$a Miovsky, Michal $u j Department of Addictology , First Faculty of Medicine, Charles University in Prague and General University Hospital , Prague 2, Czech Republic.
700    1_
$a Janikova, Barbara $u j Department of Addictology , First Faculty of Medicine, Charles University in Prague and General University Hospital , Prague 2, Czech Republic.
700    1_
$a Hovda, Knut Erik $u k The Norwegian CBRNe Centre of Medicine, Department of Acute Medicine , Oslo University Hospital , Oslo , Norway.
773    0_
$w MED00013938 $t Clinical toxicology (Philadelphia, Pa.) $x 1556-9519 $g Roč. 53, č. 9 (2015), s. 884-92
856    41
$u https://pubmed.ncbi.nlm.nih.gov/26364866 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20160408 $b ABA008
991    __
$a 20160413095029 $b ABA008
999    __
$a ok $b bmc $g 1113393 $s 934332
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 53 $c 9 $d 884-92 $e 20150912 $i 1556-9519 $m Clinical toxicology $n Clin Toxicol (Phila) $x MED00013938
LZP    __
$a Pubmed-20160408

Najít záznam

Citační ukazatele

Nahrávání dat ...

    Možnosti archivace